HK1217918A1 - 用於治療何杰金氏淋巴瘤的 -氰基- -二甲基環己- -烯- -基 -四甲基四氫- -吡喃- -基 吡啶- -基 -咪唑- -酰胺 - Google Patents
用於治療何杰金氏淋巴瘤的 -氰基- -二甲基環己- -烯- -基 -四甲基四氫- -吡喃- -基 吡啶- -基 -咪唑- -酰胺Info
- Publication number
- HK1217918A1 HK1217918A1 HK16106011.4A HK16106011A HK1217918A1 HK 1217918 A1 HK1217918 A1 HK 1217918A1 HK 16106011 A HK16106011 A HK 16106011A HK 1217918 A1 HK1217918 A1 HK 1217918A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tetramethyltetrahydro
- dimethylcyclohex
- pyran
- carboxamide
- pyridin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361792259P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/025297 WO2014151253A1 (en) | 2013-03-15 | 2014-03-13 | 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide for the treatment of hodgkin's lymphoma |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1217918A1 true HK1217918A1 (zh) | 2017-01-27 |
Family
ID=50625103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106011.4A HK1217918A1 (zh) | 2013-03-15 | 2016-05-26 | 用於治療何杰金氏淋巴瘤的 -氰基- -二甲基環己- -烯- -基 -四甲基四氫- -吡喃- -基 吡啶- -基 -咪唑- -酰胺 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20160015700A1 (zh) |
EP (1) | EP2968289A1 (zh) |
JP (1) | JP2016512836A (zh) |
CN (1) | CN105283185A (zh) |
AU (1) | AU2014235178A1 (zh) |
HK (1) | HK1217918A1 (zh) |
MX (1) | MX2015012344A (zh) |
WO (1) | WO2014151253A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI752980B (zh) * | 2016-07-18 | 2022-01-21 | 比利時商健生藥品公司 | 4-氰基-n-(2-(4,4-二甲基環己-1-烯-1-基)-6-(2,2,6,6-四甲基四氫-2h-哌喃-4-基)吡啶-3-基)-1h-咪唑-2-甲醯胺之晶型 |
WO2021263186A1 (en) * | 2020-06-26 | 2021-12-30 | Durect Corporation | Use of oxygenated cholesterol sulfates for treating inflammatory conditions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008063888A2 (en) * | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
JO3240B1 (ar) | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
-
2014
- 2014-03-13 EP EP14720331.9A patent/EP2968289A1/en not_active Withdrawn
- 2014-03-13 JP JP2016501814A patent/JP2016512836A/ja active Pending
- 2014-03-13 CN CN201480015909.2A patent/CN105283185A/zh active Pending
- 2014-03-13 WO PCT/US2014/025297 patent/WO2014151253A1/en active Application Filing
- 2014-03-13 MX MX2015012344A patent/MX2015012344A/es unknown
- 2014-03-13 AU AU2014235178A patent/AU2014235178A1/en not_active Abandoned
- 2014-03-13 US US14/772,027 patent/US20160015700A1/en not_active Abandoned
-
2016
- 2016-05-26 HK HK16106011.4A patent/HK1217918A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20160015700A1 (en) | 2016-01-21 |
EP2968289A1 (en) | 2016-01-20 |
WO2014151253A1 (en) | 2014-09-25 |
JP2016512836A (ja) | 2016-05-09 |
MX2015012344A (es) | 2016-06-02 |
CN105283185A (zh) | 2016-01-27 |
AU2014235178A1 (en) | 2015-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280573A (en) | 2-(het)aryl-converted compressed heterocycles as pest control agents | |
HK1217484A1 (zh) | 取代的 -二甲基異噁唑- -基 二氫吲哚- -酮類衍生物 | |
HK1222169A1 (zh) | 用於治療人體免疫缺損病毒 的化合物 | |
HK1210609A1 (zh) | 作為 抑制劑的氟- 噁嗪類化合物 | |
GB2523502B (en) | Adaptive exoskeleton, devices and methods for controlling the same | |
EP2826911B8 (en) | Laundry treating apparatus | |
HK1225924B (zh) | 處理過的烟草及其製備方法,包含處理過的烟草的裝置及處理過的烟草的用途 | |
HK1253372A1 (zh) | 作為bace1抑制劑的2-氨基-3-氟-3-(氟甲基)-6-甲基-6-苯基-3,4,5,6-四氫吡啶 | |
AP2015008867A0 (en) | 3,4-dihydroisquinolin-2(1h)-yl compounds | |
HK1208223A1 (zh) | 用於治療病毒感染的 -三嗪衍生物 | |
WO2014165090A8 (en) | Compounds for the treatment of tuberculosis | |
HK1212337A1 (zh) | 取代的 -環-稠合的萘並吡喃化合物 | |
EP3386952A4 (en) | SUBSTITUTED BENZIMIDAZOLIUM, PYRIDO-IMIDAZOLIUM OR PYRAZINO-IMIDAZOLIUM COMPOUNDS AS CHEMOTHERAPEUTICS | |
EP3006574A4 (en) | Heat treat furnace jig | |
SI2991983T1 (sl) | DERIVATI 2-FENIL ALI 2-HETARIL IMIDAZOL(1,2-a)PIRIDINA | |
EP2951180A4 (en) | 2,6,7,8-SUBSTITUTED PURINS AS HDM2 INHIBITORS | |
HK1216749A1 (zh) | -萘啶衍生物 | |
EP3009131A4 (en) | Agents for treating multiple myeloma | |
EP3296450A4 (en) | Clothes treating device | |
EP2953470A4 (en) | 2.6,7 SUBSTITUTED PURINS AS INHIBITORS OF HDM2 | |
HK1214258A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 | |
HK1213564A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 | |
EP3305975A4 (en) | Clothing treatment device | |
HK1217918A1 (zh) | 用於治療何杰金氏淋巴瘤的 -氰基- -二甲基環己- -烯- -基 -四甲基四氫- -吡喃- -基 吡啶- -基 -咪唑- -酰胺 | |
HK1213556A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 |